Post by
themangokid on Nov 12, 2015 6:49pm
trades at under 10x...
6 months earnings, lol, if you take this quarter and likely next quarter, as well. just playing with the math. if you annualize this quarter's results, you get $7.80 Canadian. that's under 5x earnings without amdipharm. I think management previously said amdipharm will be accretive by 25%to 30% in 2016. just to be conservative, lets apply a 15% accretive multiple to $7.80 which gets us $8.97 a share in 2016. that's a $4.23 2016 p/e. maybe I'm missing something. looks pretty good to me. anyone know of another pharma stock that's traded at under 10x earnings, for a prolonged period of time, with a growing eps profile?
Comment by
sanspeine on Nov 12, 2015 7:17pm
This post has been removed in accordance with Community Policy
Comment by
ALLOVERMEDIA on Nov 12, 2015 7:23pm
This post has been removed in accordance with Community Policy
Comment by
Marcel7 on Nov 12, 2015 7:25pm
You are so scared and trying to bury the good news on here that you are forgetting how to spell, or type, or both!